Anti-(pan)TGFβ (eg, fresolimumab) TGFβ(2) ILC2, IL-9, and IL-17- producing T cells, M2 macrophages, fibroblasts, pneumocytes Might act on different stages of COVID-19; might inhibit ST2 upregulation and IL-9 production; and has a potential benefit in pulmonary fibrosis Might inhibit regulatory T cell activity